Adverse effect of high glucose concentration on stem cell therapy

International Journal of Hematology-Oncology and Stem Cell Research

Volumn 7, Issue 3, 2013, Pages 33-39

  Saki, Najmaldin ^a   Jalalifar, Mohammad Ali ^a   Soleimani, Masoud ^b   Hajizamani, Saeideh ^a   Rahim, Fakher ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Differentiation; Glucose; Proliferation; Regulation; Stem cell therapy

Indexed keywords

GLUCOSE;

ADVERSE OUTCOME; APOPTOSIS; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE COURSE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MESENCHYMAL STEM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOPOROSIS; OXIDATIVE STRESS; PLURIPOTENT STEM CELL; REVIEW; STEM CELL EXPANSION; STEM CELL TRANSPLANTATION;

EID: 84880500385     PISSN: 17351243     EISSN: 20082207     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Larijani, B., et al., Stem cell therapy in treatment of different diseases. Acta Med Iran, 2012. 50(2): p. 79-96.
2. Brehm, M., B. Stanske, and B. E. Strauer, Therapeutic potential of stem cells in elderly patients with cardiovascular disease. Exp Gerontol, 2008. 43(11): p. 1024-32.
3. Hassiotou, F., et al., Breastmilk is a novel source of stem cells with multilineage differentiation potential. Stem Cells, 2012. 30(10): p. 2164-74.
4. Ding, V., A. B. Choo, and S. K. Oh, Deciphering the importance of three key media components in human embryonic stem cell cultures. Biotechnol Lett, 2006. 28(7): p. 491-5.
5. Scheepers, A., H. G. Joost, and A. Schurmann, The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. JPEN J Parenter Enteral Nutr, 2004. 28(5): p. 364-71.
6. Liu, J., et al., High Levels of Glucose Induced the Caspase-3/PARP Signaling Pathway, Leading to Apoptosis in Human Periodontal Ligament Fibroblasts. Cell Biochem Biophys, 2012.
7. Robertson, R. P. and J. S. Harmon, Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet beta cell. Free Radic Biol Med, 2006. 41(2): p. 177-84.
8. Stolzing, A., N. Coleman, and A. Scutt, Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res, 2006. 9(1): p. 31-5.
9. Chang, J., et al., Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway. Diabetes, 2010. 59(11): p. 2949-59.
10. Kassem, M., Stem cells: potential therapy for age-related diseases. Ann N Y Acad Sci, 2006. 1067: p. 436-42.
11. Strotmeyer, E. S., et al., Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care, 2006. 29(2): p. 306-11.
12. Butler, A. E., et al., Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes, 2003. 52(1): p. 102-10.
13. Yoon, K. H., et al., Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab, 2003. 88(5): p. 2300-8.
14. Sakuraba, H., et al., Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia, 2002. 45(1): p. 85-96.
15. Marinkovic, T., M. Sysi-Aho, and M. Oresic, Integrated Model of Metabolism and Autoimmune Response in beta-Cell Death and Progression to Type 1 Diabetes. PLoS One, 2012. 7(12): p. e51909.
16. Mathis, D., L. Vence, and C. Benoist, beta-Cell death during progression to diabetes. Nature, 2001. 414(6865): p. 792-8.
17. Robertson, R. P., et al., Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes, 2004. 53 Suppl 1: p. S119-24.
18. Stolzing, A., E. Bauer, and A. Scutt, Suspension cultures of bone-marrow-derived mesenchymal stem cells: effects of donor age and glucose level. Stem Cells Dev, 2012. 21(14): p. 2718-23.
19. Liang, C., et al., Responses of human adipose-derived mesenchymal stem cells to chemical microenvironment of the intervertebral disc. J Transl Med, 2012. 10: p. 49.
20. Elseberg, C. L., et al., Microcarrier-based expansion process for hMSCs with high vitality and undifferentiated characteristics. Int J Artif Organs, 2012. 35(2): p. 93-107.
21. Kim, Y. J., et al., miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose. Stem Cells Dev, 2012. 21(10): p. 1749-60.
22. Khan, M., et al., Growth factor preconditioning increases the function of diabetes-impaired mesenchymal stem cells. Stem Cells Dev, 2011. 20(1): p. 67-75.
23. Li, Y. M., et al., Effects of high glucose on mesenchymal stem cell proliferation and differentiation. Biochem Biophys Res Commun, 2007. 363(1): p. 209-15.
24. Keats, E. and Z. A. Khan, Unique responses of stem cell-derived vascular endothelial and mesenchymal cells to high levels of glucose. PLoS One, 2012. 7(6): p. e38752.
25. Mochizuki, H., Y. Ohnuki, and H. Kurosawa, Effect of glucose concentration during embryoid body (EB) formation from mouse embryonic stem cells on EB growth and cell differentiation. J Biosci Bioeng, 2011. 111(1): p. 92-7.
26. Howard, A. C., et al., A novel cellular defect in diabetes: membrane repair failure. Diabetes, 2011. 60(11): p. 3034-43.
27. Kim, Y. H., J. S. Heo, and H. J. Han, High glucose increase cell cycle regulatory proteins level of mouse embryonic stem cells via PI3-K/Akt and MAPKs signal pathways. J Cell Physiol, 2006. 209(1): p. 94-102.
28. McCance, D. R., et al., Diagnosing diabetes mellitus--do we need new criteria? Diabetologia, 1997. 40(3): p. 247-55.
29. Wasfy, J. H., Childhood vaccination and type 1 diabetes. N Engl J Med, 2004. 351(3): p. 298.
30. Hviid, A., et al., Childhood vaccination and type 1 diabetes. N Engl J Med, 2004. 350(14): p. 1398-404.
31. DeStefano, F., et al., Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics, 2001. 108(6): p. E112.
32. Milne, L. M., Difficulties in assessing the relationship, if any, between mumps vaccination and diabetes mellitus in childhood. Vaccine, 2000. 19(9-10): p. 1018-25.
33. Dahlquist, G. and L. Gothefors, The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia, 1995. 38(7): p. 873-4.
34. Albers, J. W., et al., Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care, 2010. 33(5): p. 1090-6.
35. Ratner, R. E., Glycemic control in the prevention of diabetic complications. Clin Cornerstone, 2001. 4(2): p. 24-37.
36. Aronson, D., Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol, 2008. 45: p. 1-16.
37. Burns, C. J., S. J. Persaud, and P. M. Jones, Diabetes mellitus: a potential target for stem cell therapy. Curr Stem Cell Res Ther, 2006. 1(2): p. 255-66.
38. Phadnis, S. M., et al., Mesenchymal stem cells derived from bone marrow of diabetic patients portrait unique markers influenced by the diabetic microenvironment. Rev Diabet Stud, 2009. 6(4): p. 260-70.
39. Gu, W., et al., Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes. Diabetes Care, 2012. 35(7): p. 1413-9.
40. Fadini, G. P., et al., Amelioration of glucose control mobilizes circulating pericyte progenitor cells in type 2 diabetic patients with microangiopathy. Exp Diabetes Res, 2012. 2012: p. 274363.
41. Li, L., et al., Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves beta-cell function in Chinese patients with new onset of type 1 diabetes. J Clin Endocrinol Metab, 2012. 97(5): p. 1729-36.
42. Ruiz-Salmeron, R., et al., Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia. Cell Transplant, 2011. 20(10): p. 1629-39.
43. Zhao, Y., et al., Reversal of type 1 diabetes via islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells. BMC Med, 2012. 10: p. 3.
44. Jiang, R., et al., Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front Med, 2011. 5(1): p. 94-100.
45. Bhansali, A., et al., Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cells Dev, 2009. 18(10): p. 1407-16.
46. Yue, T., et al., High glucose induces differentiation and adipogenesis in porcine muscle satellite cells via mTOR. BMB Rep, 2010. 43(2): p. 140-5.
47. Li, H., L. S. Jiang, and L. Y. Dai, High glucose potentiates collagen synthesis and bone morphogenetic protein-2-induced early osteoblast gene expression in rat spinal ligament cells. Endocrinology, 2010. 151(1): p. 63-74.
48. Gopalakrishnan, V., et al., Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol, 2006. 84(1): p. 93-101.
49. Kim, Y. H. and H. J. Han, Synergistic effect of high glucose and ANG II on proliferation of mouse embryonic stem cells: involvement of PKC and MAPKs as well as AT1 receptor. J Cell Physiol, 2008. 215(2): p. 374-82.
50. Aguiari, P., et al., High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc Natl Acad Sci U S A, 2008. 105(4): p. 1226-31.
51. Stanekzai, J., E. R. Isenovic, and S. A. Mousa, Treatment options for diabetes: Potential role of stem cells. Diabetes Res Clin Pract, 2012. 98(3): p. 361-8.
52. Weir, G. C., C. Cavelti-Weder, and S. Bonner-Weir, Stem cell approaches for diabetes: towards beta cell replacement. Genome Med, 2011. 3(9): p. 61.
53. Burns, C. J., S. J. Persaud, and P. M. Jones, Stem cell therapy for diabetes: do we need to make beta cells? J Endocrinol, 2004. 183(3): p. 437-43.
54. Fujikawa, T., et al., Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol, 2005. 166(6): p. 1781-91.
55. Yang, K., et al., Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells. Cardiovasc Diabetol, 2010. 9: p. 66.
56. Chen, N. X., et al., High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant, 2006. 21(12): p. 3435-42.